Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure

BACKGROUND/AIMS: The purpose of this study was to identify predictive factors for erlotinib treatment in non-small cell lung cancer (NSCLC) patients following gefitinib failure. METHODS: Forty-five patients with NSCLC who were treated with erlotinib following gefitinib failure at Seoul National Univ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Korean J Intern Med
Autors principals: Cho, Kyoung Min, Keam, Bhumsuk, Kim, Tae Min, Lee, Se-Hoon, Kim, Dong-Wan, Heo, Dae Seog
Format: Artigo
Idioma:Inglês
Publicat: The Korean Association of Internal Medicine 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4642019/
https://ncbi.nlm.nih.gov/pubmed/26552465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2015.30.6.891
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars